Case Report
Markedly Elevated Carbamazepine-10,11-epoxide/Carbamazepine Ratio in a Fatal Carbamazepine Ingestion
Table 2
Antemortem serum drawn on hospital day #3, morning (processed postmortem).
| Analytical methodology | Analyte | Serum result |
| GC/MS-EI full scan | Caffeine | Positive | HPLC-UV/VIS | Carbamazepine | 12 mcg/mL | HPLC-UV/VIS | Carbamazepine-10,11-epoxide | 54 mcg/mL | GC/MS-EI full scan | Iminostilbene | Positive | HPLC-UV/VIS | Lamotrigine | 5.7 mcg/mL | GC/MS-EI full scan | Fluoxetine | 0.3 mcg/mL | GC/MS-EI full scan | Norfluoxetine | Not detected | GC/MS-EI full scan (TMS derivative) | Hydroxyzine | Trace (less than 0.1 mcg/mL) | GC/MS-EI full scan | Hydroxyzine metabolite | Positive | GC/MS-EI full scan | Cetirizine | Positive | GC/MS-EI full scan | Laudanosine (atracurium metabolite, administered in hospital) | Not detected | LC/MS/MS-ESI | Topiramate | 28 mcg/mL | GC/MS-EI full scan | Phenytoin (administered in hospital) | Positive |
|
|